Literature DB >> 1645795

Mutational analysis of the cellular receptor for poliovirus.

M S Freistadt1, V R Racaniello.   

Abstract

To identify sequences of the cellular poliovirus receptor (PVR) involved in viral infection, mutant PVR cDNAs were constructed and assayed for biological activity in mouse L cells. To confirm that mutant PVRs reached the cell surface, an immunological tag, consisting of part of CH3 from human immunoglobulin G1, was engineered into the PVR. Deletion of PVR amino acids 256 to 320 or 385 to the carboxy terminus yielded receptors that were able to support poliovirus infection. PVRs lacking amino acids 40 to 136 or 137 to 256 were expressed at the cell surface but were not active as receptors for poliovirus. The results show that immunoglobulin-type domain 3 and the extreme carboxy terminus of the PVR are not required for viral receptor function, but sequences within the two amino-terminal domains contribute to the initiation of poliovirus infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645795      PMCID: PMC241418     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Crystal structure of an HIV-binding recombinant fragment of human CD4.

Authors:  S E Ryu; P D Kwong; A Truneh; T G Porter; J Arthos; M Rosenberg; X P Dai; N H Xuong; R Axel; R W Sweet
Journal:  Nature       Date:  1990-11-29       Impact factor: 49.962

2.  Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains.

Authors:  J H Wang; Y W Yan; T P Garrett; J H Liu; D W Rodgers; R L Garlick; G E Tarr; Y Husain; E L Reinherz; S C Harrison
Journal:  Nature       Date:  1990-11-29       Impact factor: 49.962

3.  The chromic chloride method of coupling antigens to erythrocytes: definition of some important parameters.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

4.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

5.  Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.

Authors:  C L Mendelsohn; E Wimmer; V R Racaniello
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

6.  Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.

Authors:  M D Moore; N R Cooper; B F Tack; G R Nemerow
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site.

Authors:  P Nobis; R Zibirre; G Meyer; J Kühne; G Warnecke; G Koch
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

8.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

9.  Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies.

Authors:  J L Dangl; T G Wensel; S L Morrison; L Stryer; L A Herzenberg; V T Oi
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

10.  The poliovirus receptor protein is produced both as membrane-bound and secreted forms.

Authors:  S Koike; H Horie; I Ise; A Okitsu; M Yoshida; N Iizuka; K Takeuchi; T Takegami; A Nomoto
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  12 in total

1.  Interaction of the poliovirus receptor with poliovirus.

Authors:  Y He; V D Bowman; S Mueller; C M Bator; J Bella; X Peng; T S Baker; E Wimmer; R J Kuhn; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  A chimeric poliovirus/CD4 receptor confers susceptibility to poliovirus on mouse cells.

Authors:  H C Selinka; A Zibert; E Wimmer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 3.  Virus receptors: implications for pathogenesis and the design of antiviral agents.

Authors:  L C Norkin
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

4.  N glycosylation of the virus binding domain is not essential for function of the human poliovirus receptor.

Authors:  A Zibert; E Wimmer
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome.

Authors:  Seii Ohka; Norie Matsuda; Koujiro Tohyama; Toshiyuki Oda; Masato Morikawa; Shusuke Kuge; Akio Nomoto
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Structure of a human rhinovirus complexed with its receptor molecule.

Authors:  N H Olson; P R Kolatkar; M A Oliveira; R H Cheng; J M Greve; A McClelland; T S Baker; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

7.  Crystallographic and cryo EM analysis of virion-receptor interactions.

Authors:  M G Rossmann; N H Olson; P R Kolatkar; M A Oliveira; R H Cheng; J M Greve; A McClelland; T S Baker
Journal:  Arch Virol Suppl       Date:  1994

8.  Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain.

Authors:  G S Dveksler; A A Basile; C B Cardellichio; K V Holmes
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

9.  Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons.

Authors:  Seii Ohka; Mai Sakai; Stephanie Bohnert; Hiroko Igarashi; Katrin Deinhardt; Giampietro Schiavo; Akio Nomoto
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

Review 10.  Viral cell recognition and entry.

Authors:  M G Rossmann
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.